In a prospective , single-center , randomized , controlled , open-label pilot study , patients hospitalized with AHF were randomly assigned to receive oral high-dose atorvastatin loading ( 80 mg for 3 days , followed by 10 mg/day until discharge ) or no statin therapy , on top of optimal HF treatment .